VF
STLN

Virtu Financial’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Virtu Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41K Buy
+13,213
New +$40.5K ﹤0.01% 1317
2025
Q1 		– Sell
-131,759
Closed -$41K – 2033
2024
Q4 		$41K Buy
+131,759
New +$34.2K ﹤0.01% 1188
2023
Q4 		– Sell
-14,044
Closed -$20K – 2005
2023
Q3 		$20K Buy
+14,044
New +$14.5K ﹤0.01% 1017

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's STLN Position: Q1 2026 in Review

Virtu Financial opened a new position in Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2026: 13,213 shares worth $41K. The stake represents ﹤0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Virtu Financial previously reported a position in STLN as recently as Q4 2024.

Virtu Financial first reported a position in STLN in Q3 2023 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Virtu Financial held 13,213 shares of Starling Oncology Institute, Inc. Common Stock worth $41K as of Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock was a new Virtu Financial position in Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1317 holding.
  • Virtu Financial first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2023 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.